The lowering of AGEs has been proposed as a treatment for diabetic CVD, as AGE inhibiting compounds, such as alagebrium, and pyridoxamine have been shown to reduce atherosclerosis in diabetic Apoe−/− mice (26). This evidence concerns the gene APOE and atherosclerosis.